Mutated SON putatively causes a cancer syndrome comprising high-risk medulloblastoma combined with café-au-lait spots

Medulloblastoma is the most frequent malignant brain tumor in childhood. This highly malignant neoplasm occurs usually before 10 years of age and more frequently in boys. The 5-year event-free survival rate for high-risk medulloblastoma is low at 62% despite a multimodal therapy including surgical r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Familial cancer 2019-07, Vol.18 (3), p.353-358
Hauptverfasser: Chiu, Celine, Loth, Stefanie, Kuhlen, Michaela, Ginzel, Sebastian, Schaper, Jörg, Rosenbaum, Thorsten, Pietsch, Torsten, Borkhardt, Arndt, Hoell, Jessica I.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 358
container_issue 3
container_start_page 353
container_title Familial cancer
container_volume 18
creator Chiu, Celine
Loth, Stefanie
Kuhlen, Michaela
Ginzel, Sebastian
Schaper, Jörg
Rosenbaum, Thorsten
Pietsch, Torsten
Borkhardt, Arndt
Hoell, Jessica I.
description Medulloblastoma is the most frequent malignant brain tumor in childhood. This highly malignant neoplasm occurs usually before 10 years of age and more frequently in boys. The 5-year event-free survival rate for high-risk medulloblastoma is low at 62% despite a multimodal therapy including surgical resection, radiation therapy and chemotherapy. We report the case of a boy, who was born to consanguineous parents. Prominently, he had multiple café-au-lait spots. At the age of 3 years he was diagnosed with a high-risk metastatic medulloblastoma. The patient died only 11 months after diagnosis of a fulminant relapse presenting as meningeal and spinal dissemination. Whole-exome sequencing of germline DNA was employed to detect the underlying mutation for this putative cancer syndrome presenting with the combination of medulloblastoma and skin alterations. After screening all possible homozygous gene SNVs, we identified a mutation of SON , an essential protein in cell cycle regulation and cell proliferation, as the most likely genetic cause.
doi_str_mv 10.1007/s10689-019-00121-z
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2179423828</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2170788906</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-29ca982cab57b685d3c833c12cff170ecdfdf077b84fde46b7e8a03fe15802a73</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhS0Eoj_wAiyQJTZsDNf2JHaWqAKKVNoFsLYcx55JSeLBNymavhHPwYv1DlNAYsHC8pHud46texh7JuGVBDCvUUJtGwGSDkglxe0Ddiwro4VRjXpIWtO4qQGO2AniNYACpc1jdqTJCCsDx-zm4zL7OXb809Ul3-51fxOHHQ9-wYjck5hCLBx3U1fyGHnI47b02E9rvunXG0H6Kx9jtwxDbgePcx79Hmr7iVK_9_OGItLPH8IvYvD9zHGbZ3zCHiU_YHx6f5-yL-_efj47FxdX7z-cvbkQQZtqFqoJvrEq-LYybW2rTgerdZAqpCQNxNClLoExrV2lLq7q1kTrQacoKwvKG33KXh5ytyV_WyLObuwxxGHwU8wLOiVNs1LaKkvoi3_Q67yUiX63p8BY20BNlDpQoWTEEpOjbYy-7JwEt2_FHVpx1Ir71Yq7JdPz--ilpVX9sfyugQB9AJBG0zqWv2__J_YOndObEw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2170788906</pqid></control><display><type>article</type><title>Mutated SON putatively causes a cancer syndrome comprising high-risk medulloblastoma combined with café-au-lait spots</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Chiu, Celine ; Loth, Stefanie ; Kuhlen, Michaela ; Ginzel, Sebastian ; Schaper, Jörg ; Rosenbaum, Thorsten ; Pietsch, Torsten ; Borkhardt, Arndt ; Hoell, Jessica I.</creator><creatorcontrib>Chiu, Celine ; Loth, Stefanie ; Kuhlen, Michaela ; Ginzel, Sebastian ; Schaper, Jörg ; Rosenbaum, Thorsten ; Pietsch, Torsten ; Borkhardt, Arndt ; Hoell, Jessica I.</creatorcontrib><description>Medulloblastoma is the most frequent malignant brain tumor in childhood. This highly malignant neoplasm occurs usually before 10 years of age and more frequently in boys. The 5-year event-free survival rate for high-risk medulloblastoma is low at 62% despite a multimodal therapy including surgical resection, radiation therapy and chemotherapy. We report the case of a boy, who was born to consanguineous parents. Prominently, he had multiple café-au-lait spots. At the age of 3 years he was diagnosed with a high-risk metastatic medulloblastoma. The patient died only 11 months after diagnosis of a fulminant relapse presenting as meningeal and spinal dissemination. Whole-exome sequencing of germline DNA was employed to detect the underlying mutation for this putative cancer syndrome presenting with the combination of medulloblastoma and skin alterations. After screening all possible homozygous gene SNVs, we identified a mutation of SON , an essential protein in cell cycle regulation and cell proliferation, as the most likely genetic cause.</description><identifier>ISSN: 1389-9600</identifier><identifier>EISSN: 1573-7292</identifier><identifier>DOI: 10.1007/s10689-019-00121-z</identifier><identifier>PMID: 30680470</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Biomedical and Life Sciences ; Biomedicine ; Brain cancer ; Brain tumors ; Cafe-au-Lait Spots - genetics ; Cancer ; Cancer Research ; Cell cycle ; Cell proliferation ; Cerebellar Neoplasms - genetics ; Chemotherapy ; Child, Preschool ; Children ; Consanguinity ; Deoxyribonucleic acid ; DNA ; DNA sequencing ; DNA-Binding Proteins - genetics ; Epidemiology ; Fatal Outcome ; Human Genetics ; Humans ; Male ; Medulloblastoma ; Medulloblastoma - genetics ; Metastases ; Minor Histocompatibility Antigens - genetics ; Mutation ; Pedigree ; Point Mutation ; Radiation therapy ; Short Communication ; Skin ; Syndrome</subject><ispartof>Familial cancer, 2019-07, Vol.18 (3), p.353-358</ispartof><rights>Springer Nature B.V. 2019</rights><rights>Familial Cancer is a copyright of Springer, (2019). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-29ca982cab57b685d3c833c12cff170ecdfdf077b84fde46b7e8a03fe15802a73</citedby><cites>FETCH-LOGICAL-c375t-29ca982cab57b685d3c833c12cff170ecdfdf077b84fde46b7e8a03fe15802a73</cites><orcidid>0000-0002-5532-9845</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10689-019-00121-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10689-019-00121-z$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51297</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30680470$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chiu, Celine</creatorcontrib><creatorcontrib>Loth, Stefanie</creatorcontrib><creatorcontrib>Kuhlen, Michaela</creatorcontrib><creatorcontrib>Ginzel, Sebastian</creatorcontrib><creatorcontrib>Schaper, Jörg</creatorcontrib><creatorcontrib>Rosenbaum, Thorsten</creatorcontrib><creatorcontrib>Pietsch, Torsten</creatorcontrib><creatorcontrib>Borkhardt, Arndt</creatorcontrib><creatorcontrib>Hoell, Jessica I.</creatorcontrib><title>Mutated SON putatively causes a cancer syndrome comprising high-risk medulloblastoma combined with café-au-lait spots</title><title>Familial cancer</title><addtitle>Familial Cancer</addtitle><addtitle>Fam Cancer</addtitle><description>Medulloblastoma is the most frequent malignant brain tumor in childhood. This highly malignant neoplasm occurs usually before 10 years of age and more frequently in boys. The 5-year event-free survival rate for high-risk medulloblastoma is low at 62% despite a multimodal therapy including surgical resection, radiation therapy and chemotherapy. We report the case of a boy, who was born to consanguineous parents. Prominently, he had multiple café-au-lait spots. At the age of 3 years he was diagnosed with a high-risk metastatic medulloblastoma. The patient died only 11 months after diagnosis of a fulminant relapse presenting as meningeal and spinal dissemination. Whole-exome sequencing of germline DNA was employed to detect the underlying mutation for this putative cancer syndrome presenting with the combination of medulloblastoma and skin alterations. After screening all possible homozygous gene SNVs, we identified a mutation of SON , an essential protein in cell cycle regulation and cell proliferation, as the most likely genetic cause.</description><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Brain cancer</subject><subject>Brain tumors</subject><subject>Cafe-au-Lait Spots - genetics</subject><subject>Cancer</subject><subject>Cancer Research</subject><subject>Cell cycle</subject><subject>Cell proliferation</subject><subject>Cerebellar Neoplasms - genetics</subject><subject>Chemotherapy</subject><subject>Child, Preschool</subject><subject>Children</subject><subject>Consanguinity</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>DNA sequencing</subject><subject>DNA-Binding Proteins - genetics</subject><subject>Epidemiology</subject><subject>Fatal Outcome</subject><subject>Human Genetics</subject><subject>Humans</subject><subject>Male</subject><subject>Medulloblastoma</subject><subject>Medulloblastoma - genetics</subject><subject>Metastases</subject><subject>Minor Histocompatibility Antigens - genetics</subject><subject>Mutation</subject><subject>Pedigree</subject><subject>Point Mutation</subject><subject>Radiation therapy</subject><subject>Short Communication</subject><subject>Skin</subject><subject>Syndrome</subject><issn>1389-9600</issn><issn>1573-7292</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kc1u1DAUhS0Eoj_wAiyQJTZsDNf2JHaWqAKKVNoFsLYcx55JSeLBNymavhHPwYv1DlNAYsHC8pHud46texh7JuGVBDCvUUJtGwGSDkglxe0Ddiwro4VRjXpIWtO4qQGO2AniNYACpc1jdqTJCCsDx-zm4zL7OXb809Ul3-51fxOHHQ9-wYjck5hCLBx3U1fyGHnI47b02E9rvunXG0H6Kx9jtwxDbgePcx79Hmr7iVK_9_OGItLPH8IvYvD9zHGbZ3zCHiU_YHx6f5-yL-_efj47FxdX7z-cvbkQQZtqFqoJvrEq-LYybW2rTgerdZAqpCQNxNClLoExrV2lLq7q1kTrQacoKwvKG33KXh5ytyV_WyLObuwxxGHwU8wLOiVNs1LaKkvoi3_Q67yUiX63p8BY20BNlDpQoWTEEpOjbYy-7JwEt2_FHVpx1Ir71Yq7JdPz--ilpVX9sfyugQB9AJBG0zqWv2__J_YOndObEw</recordid><startdate>20190701</startdate><enddate>20190701</enddate><creator>Chiu, Celine</creator><creator>Loth, Stefanie</creator><creator>Kuhlen, Michaela</creator><creator>Ginzel, Sebastian</creator><creator>Schaper, Jörg</creator><creator>Rosenbaum, Thorsten</creator><creator>Pietsch, Torsten</creator><creator>Borkhardt, Arndt</creator><creator>Hoell, Jessica I.</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9-</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5532-9845</orcidid></search><sort><creationdate>20190701</creationdate><title>Mutated SON putatively causes a cancer syndrome comprising high-risk medulloblastoma combined with café-au-lait spots</title><author>Chiu, Celine ; Loth, Stefanie ; Kuhlen, Michaela ; Ginzel, Sebastian ; Schaper, Jörg ; Rosenbaum, Thorsten ; Pietsch, Torsten ; Borkhardt, Arndt ; Hoell, Jessica I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-29ca982cab57b685d3c833c12cff170ecdfdf077b84fde46b7e8a03fe15802a73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Brain cancer</topic><topic>Brain tumors</topic><topic>Cafe-au-Lait Spots - genetics</topic><topic>Cancer</topic><topic>Cancer Research</topic><topic>Cell cycle</topic><topic>Cell proliferation</topic><topic>Cerebellar Neoplasms - genetics</topic><topic>Chemotherapy</topic><topic>Child, Preschool</topic><topic>Children</topic><topic>Consanguinity</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>DNA sequencing</topic><topic>DNA-Binding Proteins - genetics</topic><topic>Epidemiology</topic><topic>Fatal Outcome</topic><topic>Human Genetics</topic><topic>Humans</topic><topic>Male</topic><topic>Medulloblastoma</topic><topic>Medulloblastoma - genetics</topic><topic>Metastases</topic><topic>Minor Histocompatibility Antigens - genetics</topic><topic>Mutation</topic><topic>Pedigree</topic><topic>Point Mutation</topic><topic>Radiation therapy</topic><topic>Short Communication</topic><topic>Skin</topic><topic>Syndrome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chiu, Celine</creatorcontrib><creatorcontrib>Loth, Stefanie</creatorcontrib><creatorcontrib>Kuhlen, Michaela</creatorcontrib><creatorcontrib>Ginzel, Sebastian</creatorcontrib><creatorcontrib>Schaper, Jörg</creatorcontrib><creatorcontrib>Rosenbaum, Thorsten</creatorcontrib><creatorcontrib>Pietsch, Torsten</creatorcontrib><creatorcontrib>Borkhardt, Arndt</creatorcontrib><creatorcontrib>Hoell, Jessica I.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Familial cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chiu, Celine</au><au>Loth, Stefanie</au><au>Kuhlen, Michaela</au><au>Ginzel, Sebastian</au><au>Schaper, Jörg</au><au>Rosenbaum, Thorsten</au><au>Pietsch, Torsten</au><au>Borkhardt, Arndt</au><au>Hoell, Jessica I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mutated SON putatively causes a cancer syndrome comprising high-risk medulloblastoma combined with café-au-lait spots</atitle><jtitle>Familial cancer</jtitle><stitle>Familial Cancer</stitle><addtitle>Fam Cancer</addtitle><date>2019-07-01</date><risdate>2019</risdate><volume>18</volume><issue>3</issue><spage>353</spage><epage>358</epage><pages>353-358</pages><issn>1389-9600</issn><eissn>1573-7292</eissn><abstract>Medulloblastoma is the most frequent malignant brain tumor in childhood. This highly malignant neoplasm occurs usually before 10 years of age and more frequently in boys. The 5-year event-free survival rate for high-risk medulloblastoma is low at 62% despite a multimodal therapy including surgical resection, radiation therapy and chemotherapy. We report the case of a boy, who was born to consanguineous parents. Prominently, he had multiple café-au-lait spots. At the age of 3 years he was diagnosed with a high-risk metastatic medulloblastoma. The patient died only 11 months after diagnosis of a fulminant relapse presenting as meningeal and spinal dissemination. Whole-exome sequencing of germline DNA was employed to detect the underlying mutation for this putative cancer syndrome presenting with the combination of medulloblastoma and skin alterations. After screening all possible homozygous gene SNVs, we identified a mutation of SON , an essential protein in cell cycle regulation and cell proliferation, as the most likely genetic cause.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><pmid>30680470</pmid><doi>10.1007/s10689-019-00121-z</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-5532-9845</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1389-9600
ispartof Familial cancer, 2019-07, Vol.18 (3), p.353-358
issn 1389-9600
1573-7292
language eng
recordid cdi_proquest_miscellaneous_2179423828
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Biomedical and Life Sciences
Biomedicine
Brain cancer
Brain tumors
Cafe-au-Lait Spots - genetics
Cancer
Cancer Research
Cell cycle
Cell proliferation
Cerebellar Neoplasms - genetics
Chemotherapy
Child, Preschool
Children
Consanguinity
Deoxyribonucleic acid
DNA
DNA sequencing
DNA-Binding Proteins - genetics
Epidemiology
Fatal Outcome
Human Genetics
Humans
Male
Medulloblastoma
Medulloblastoma - genetics
Metastases
Minor Histocompatibility Antigens - genetics
Mutation
Pedigree
Point Mutation
Radiation therapy
Short Communication
Skin
Syndrome
title Mutated SON putatively causes a cancer syndrome comprising high-risk medulloblastoma combined with café-au-lait spots
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T20%3A54%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mutated%20SON%20putatively%20causes%20a%20cancer%20syndrome%20comprising%20high-risk%20medulloblastoma%20combined%20with%20caf%C3%A9-au-lait%20spots&rft.jtitle=Familial%20cancer&rft.au=Chiu,%20Celine&rft.date=2019-07-01&rft.volume=18&rft.issue=3&rft.spage=353&rft.epage=358&rft.pages=353-358&rft.issn=1389-9600&rft.eissn=1573-7292&rft_id=info:doi/10.1007/s10689-019-00121-z&rft_dat=%3Cproquest_cross%3E2170788906%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2170788906&rft_id=info:pmid/30680470&rfr_iscdi=true